Industry reports
Editor highlights

Publication dates

data types

Granulocyte Market and Forecasts, April 2014

You might be interested in: biosimilar, blood supply, cytokine, more »


 
1-10 of 62 reports for Granulocyte

Biological Therapy Industry Analysis

  • Industry report
  • February 2013
  • 55 pages

... Q-pcr: leukocytes Spectracell Telome health Flow-fish: lymphocytes and granulocytes Repeat diagnostics Ht q-fish percent shortest telomeres Life length replicative senescence: why does ...

Gm-csf Market Overview

  • Industry report
  • April 2013
  • 44 pages

... And differentiation in granulocytes, macrophages and eosinophils. Because of proliferative effects on fibroblasts, one therefore can hypothesize that gm-csf may expand endometrial thickness even more than g ...

Biotechnology Industry in The United States and Japan

  • Industry report
  • December 2013
  • 8 pages

... granulocyte colony-stimulating factor (g-csf) 1989 epogen (epoetin alfa) is approved 1991 neupogen (filgrastim) is approved 2001 aranesp (darbepoetin alfa) is approved 2002 immunex, developer ...

Pharmaceutical Market in India and The United Kingdom

  • Industry report
  • March 2012
  • 2 pages

... Blood cell (rbc) and platelet (plt) transfusions. Significantly greater accumulation of pulmonary granulocytes and higher serum mip-2 in mice with severe combined immunodeficiency, upon infusion ...

The Future of Biological Therapy

  • Industry report
  • April 2012
  • 20 pages

... Extremely potent stimulator of the immune system Strongly enhances effector function of dendritic cells and macrophages Indispensable for growth and development of granulocytes and macrophages Strong ...

The Lithuanian Biopharmaceutical Business : Innovation and Technology Trends

  • Industry report
  • September 2012
  • 32 pages

... Vilnius, 12/09/2012 9 uab sicor biotech-teva produces two active pharmaceutical ingredients: Recombinant human granulocyte colony stimulating factor (g-csf); Recombinant human interferon alfa-2b ...

Biosimilar Sector in Europe

  • Industry report
  • September 2013
  • 16 pages

... In this review we provide an overview of data related to switching between human recombinant growth hormones, erythropoietins and granulocyte colony stimulating agents. We reviewed data from clinical trials ...

Biosimilar Market in Europe

  • Industry report
  • September 2013
  • 16 pages

... In this review we provide an overview of data related to switching between human recombinant growth hormones, erythropoietins and granulocyte colony stimulating agents. We reviewed data from clinical trials ...

The Future of The Indian Biopharmaceutical

  • Industry report
  • October 2012
  • 21 pages

... Comprise of human insulin, human growth hormone, granulocyte colony stimulating factor (g-csf), erythropoietin, and streptokinase. Recent estimates indicate that 20 companies in india are already ...

The Spanish Protein Industry (protein, recombinant protein)

  • Industry report
  • October 2013
  • 4 pages

... Proteins [35] udoalteromonas haloplanktis 3h6 fab [38] human nerve growth factor [39] ella sp. Strain ac10 -lactamase, peptidases, glucosidase [40] pseudomonas fluorescens human granulocyte colony ...

» Read our Company Profiles

2 Companies for Granulocyte

Citrix

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.